reviewNature reviews. ImmunologyApr 17, 2015Closed access

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

DKDavid Klatzmann AKAbul K. Abbas

Inserm · Sorbonne Université · +3 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

618

total citations

FWCI: 25.83
Percentile: 100%
References: 123

Citations per year

Authors

2

DK
David KlatzmannCorresponding
Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Immunologie - Immunopathologie - Immunothérapie
AK
Abul K. AbbasCorresponding
University of California, San Francisco

Topics & keywords

Topics

Keywords

Immunology
Inflammation
Effector
Immune system
Disease
Treg cell
Medicine
Autoimmune disease

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.